Correlation Between Goldman Sachs and Biotechnology Fund
Can any of the company-specific risk be diversified away by investing in both Goldman Sachs and Biotechnology Fund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Goldman Sachs and Biotechnology Fund into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Goldman Sachs Short and Biotechnology Fund Class, you can compare the effects of market volatilities on Goldman Sachs and Biotechnology Fund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Goldman Sachs with a short position of Biotechnology Fund. Check out your portfolio center. Please also check ongoing floating volatility patterns of Goldman Sachs and Biotechnology Fund.
Diversification Opportunities for Goldman Sachs and Biotechnology Fund
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Goldman and Biotechnology is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Goldman Sachs Short and Biotechnology Fund Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Fund Class and Goldman Sachs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Goldman Sachs Short are associated (or correlated) with Biotechnology Fund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Fund Class has no effect on the direction of Goldman Sachs i.e., Goldman Sachs and Biotechnology Fund go up and down completely randomly.
Pair Corralation between Goldman Sachs and Biotechnology Fund
Assuming the 90 days horizon Goldman Sachs is expected to generate 4.35 times less return on investment than Biotechnology Fund. But when comparing it to its historical volatility, Goldman Sachs Short is 14.38 times less risky than Biotechnology Fund. It trades about 0.07 of its potential returns per unit of risk. Biotechnology Fund Class is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 5,684 in Biotechnology Fund Class on December 9, 2024 and sell it today you would earn a total of 19.00 from holding Biotechnology Fund Class or generate 0.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Goldman Sachs Short vs. Biotechnology Fund Class
Performance |
| Timeline |
| Goldman Sachs Short |
| Biotechnology Fund Class |
Goldman Sachs and Biotechnology Fund Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Goldman Sachs and Biotechnology Fund
The main advantage of trading using opposite Goldman Sachs and Biotechnology Fund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Goldman Sachs position performs unexpectedly, Biotechnology Fund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Fund will offset losses from the drop in Biotechnology Fund's long position.| Goldman Sachs vs. Goldman Sachs Technology | ||
| Goldman Sachs vs. Dreyfus Technology Growth | ||
| Goldman Sachs vs. Health Biotchnology Portfolio | ||
| Goldman Sachs vs. Vanguard Information Technology |
| Biotechnology Fund vs. Mid Cap 15x Strategy | ||
| Biotechnology Fund vs. Oberweis Small Cap Opportunities | ||
| Biotechnology Fund vs. T Rowe Price | ||
| Biotechnology Fund vs. Fidelity Small Cap |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |